J&J’s Codman Neuro Recall Upgraded to High Risk Class I

Codman Neuro, a division of Johnson & Johnson subsidiary DePuy Synthes, said the FDA labeled its Trufill n-BCA liquid embolic system recall as Class I, the federal watchdog agency’s highest-risk classification.
MassDevice